Heinemann L - Search Results

1

Advances in Insulin Pump Infusion Sets Symposium Report.

Zhang JY, Shang T, Chattaraj S, Cohen O, Heschel M, Vigersky RA, Heinemann L, Nørgaard K, Svensson J, Buckingham B, Klonoff DC. Zhang JY, et al. Among authors: heinemann l. J Diabetes Sci Technol. 2021 May;15(3):705-709. doi: 10.1177/1932296821999080. Epub 2021 Mar 11. J Diabetes Sci Technol. 2021. PMID: 33703930 Free PMC article.

2

Chronic intermittent intravenous insulin therapy: really a new therapeutic option?

Heinemann L. Heinemann L. Diabetes Technol Ther. 2001 Spring;3(1):125-7. doi: 10.1089/152091501750220082. Diabetes Technol Ther. 2001. PMID: 11469702 No abstract available.

3

Variability of insulin absorption and insulin action.

Heinemann L. Heinemann L. Diabetes Technol Ther. 2002;4(5):673-82. doi: 10.1089/152091502320798312. Diabetes Technol Ther. 2002. PMID: 12450450 Review.

4

Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol.

Kapitza C, Heise T, Fishman RS, Shapiro DA, Gopalakrishnan V, Rave K, Bott S, Perera AD, Heinemann L. Kapitza C, et al. Among authors: heinemann l. Diabetes Technol Ther. 2004 Apr;6(2):119-27. doi: 10.1089/152091504773731302. Diabetes Technol Ther. 2004. PMID: 15117578 Clinical Trial.

5

Measurement of insulin absorption and insulin action.

Heinemann L, Anderson JH Jr. Heinemann L, et al. Diabetes Technol Ther. 2004 Oct;6(5):698-718. doi: 10.1089/dia.2004.6.698. Diabetes Technol Ther. 2004. PMID: 15628821 Review.

6

The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles.

Thomas A, Schönauer M, Achermann F, Schnell O, Hanefeld M, Ziegelasch HJ, Mastrototaro J, Heinemann L. Thomas A, et al. Among authors: heinemann l. Diabetes Technol Ther. 2009 Jun;11(6):399-409. doi: 10.1089/dia.2008.0119. Diabetes Technol Ther. 2009. PMID: 19459770

7

Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes.

Heinemann L, Nosek L, Kapitza C, Schweitzer MA, Krinelke L. Heinemann L, et al. Diabetes Care. 2009 Aug;32(8):1437-9. doi: 10.2337/dc09-0595. Epub 2009 Jun 1. Diabetes Care. 2009. PMID: 19487635 Free PMC article. Clinical Trial.

8

Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device.

Kapitza C, Fein S, Heinemann L, Schleusener D, Levesque S, Strange P. Kapitza C, et al. Among authors: heinemann l. J Diabetes Sci Technol. 2008 Jan;2(1):40-6. doi: 10.1177/193229680800200107. J Diabetes Sci Technol. 2008. PMID: 19885176 Free PMC article.

9

Oral insulin and buccal insulin: a critical reappraisal.

Heinemann L, Jacques Y. Heinemann L, et al. J Diabetes Sci Technol. 2009 May 1;3(3):568-84. doi: 10.1177/193229680900300323. J Diabetes Sci Technol. 2009. PMID: 20144297 Free PMC article. Review.

10

Insulin pump therapy: what is the evidence for using different types of boluses for coverage of prandial insulin requirements?

Heinemann L. Heinemann L. J Diabetes Sci Technol. 2009 Nov 1;3(6):1490-500. doi: 10.1177/193229680900300631. J Diabetes Sci Technol. 2009. PMID: 20144405 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters